Susquehanna Fundamental Investments, LLC Neurocrine Biosciences Inc Transaction History
Susquehanna Fundamental Investments, LLC
- $4.33 Trillion
- Q2 2024
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 3,695 shares of NBIX stock, worth $421,673. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,695Holding current value
$421,673% of portfolio
0.01%Shares
6 transactions
Others Institutions Holding NBIX
# of Institutions
641Shares Held
95.3MCall Options Held
661KPut Options Held
227K-
Black Rock Inc. New York, NY14.2MShares$1.62 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.15 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$526 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$282 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$270 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...